The surge in demand for semaglutide has channelled the off-label use of Ozempic and Rybelsus for weight management, further straining the supply of these medications for use in T2D
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
The side effects we occasionally see in clinic are mild and typically transient
GLP-1 for weight loss Medically reviewed by Dr Crystal Wyllie Last reviewed: 19 Jun 2026 Glucagon-like peptide-1 (GLP-1) agonists are a popular weight loss treatment in the UK
Ive been [injecting] GHK-Cu at 2-3mg per day for 12 weeks now and honestly, my skin has never looked worse, wrote one user on Reddit
Todos los tratamientos son prescritos por mdicos con licencia europea tras revisar tu historial mdico